Every batch is laboratory tested for quality assurance
Pfizer, Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron, Press Release, July 11, 2024
That is worth stating clearly upfront
How often will I need regular follow-up appointments while on a GLP-1
IV therapy delivers it directly into the bloodstream at a much higher concentration than is achievable through diet or oral supplements, supporting detoxification, cellular repair and skin brightening
In the STEP-1 extension trial, participants who discontinued semaglutide after 68 weeks regained a mean of 11.6%-points of body weight over the subsequent year, compared to 1.9%-points in the placebo group [97]